SEC Talis Biomedical 2020 Revenues Rise Sharply The company also said it is planning on filing for Emergency Use Authorization for its SARS-CoV-2 test in the second quarter of 2021. SEC Sues Founders of Bankrupt Human Microbiome Testing Firm uBiome For Fraud The US Securities and Exchange Commission alleges that uBiome's founders misled investors in order to close a Series C financing round in 2018. Abbott Enters $5B Credit Agreement Abbott has terminated its prior $5 billion credit agreement also with JP Morgan reached in November 2018. Hologic Raises Q4 Revenue Guidance The increased forecast is the result of continuing COVID-19 testing volumes along with recovery in its breast and skeletal business, Hologic said. Early Cancer Detection Firm Grail Files for IPO The company is developing a blood-based test to detect more than 50 cancer types across all stages and identify a tumor's tissue of origin. Aug 20, 2020 Aiming to Put Regulatory, Payor Issues in Past, Progenity Progresses With Women's Health Pipeline Premium Jun 16, 2020 Progenity Eyes $122.6M in Amended IPO Jun 15, 2020 Genetron Health Targeting $175.5M in Amended US IPO Jun 10, 2020 Danaher Replaces Previous $5B Credit Facility with New $2.5B Facility Jun 7, 2020 ArcherDx Targeting $100M in IPO Apr 27, 2020 SeqLL Withdraws Plans for $8M IPO Feb 12, 2020 OpGen Preliminary 2019 Revenues up 19 Percent Jan 24, 2020 Adaptive Biotechnologies Prices Public Offering of Stock Dec 17, 2019 Grail Raises $125M in Equity Financing Offering Dec 2, 2019 Genetron Health Gets China NMPA Approval for Clinical NGS System, Files for IPO Oct 15, 2019 OpGen Plans $10.4M Stock, Warrant Sale Sep 4, 2019 Danaher Offering €6.20B in Senior Notes Aug 30, 2019 Danaher Enters Into $10B Loan Agreements Aug 28, 2019 OpGen Plans Reverse Stock Split Aug 13, 2019 Fulgent Genetics to Offer $75M of Securities Jul 10, 2019 Former Illumina Accountant Pleads Guilty to Insider Trading Mar 6, 2019 Invitae Expects to Raise at Least $171M in Common Stock Offering Mar 5, 2019 Invitae Launches $125M Common Stock Offering Mar 4, 2019 OpGen Files for $6.5M Public Offering of Common Stock Feb 8, 2019 Biocept Prices $7.5M Public Offering of Stocks, Warrants Load More Breaking News Roche Receives FDA EUA for PCR-Based, Point-of-Care SARS-CoV-2 Test Decode Study Identifies Proteomic Predictors of All-Cause Mortality In Brief This Week: Natera, Bruker, Bayer, and More New Products Posted to GenomeWeb: Labcorp, Omniseq, Dovetail Genomics, DNA Script, More People in the News: New Appointments at Sema4, Strata Oncology, Bionano Genomics, More Co-Diagnostics Gets CE Mark for Saliva-Based Molecular SARS-CoV-2 Test The Scan Billions for Antivirals The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports. NFT of the Web Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports. 23andMe on the Nasdaq 23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported. Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.